HT-related decrease in breast density may cause breast cancer Clinical study 19 January 2013 Pages: 1 - 1
Following an alert from the Singapore Health Sciences Authority, Health Canada has advised consumers not to use Urat Madu News item 19 January 2013 Pages: 2 - 2
CollaGenex Pharmaceuticals has discontinued treatment of all enrolled patients in the 40mg cohort of its Phase II dose-finding study of incyclinide Media release 19 January 2013 Pages: 2 - 2
Astellas Pharma Inc has announced that, in the US phase II clinical trial of FG-2216 Media release 19 January 2013 Pages: 3 - 3
The use of oral progestogens by women over 40 years of age may increase breast cancer risk Clinical study 19 January 2013 Pages: 5 - 5
Cilastatin effectively reduces the incidence of acute ciclosporin-induced nephrotoxicity among transplant recipients Clinical study 19 January 2013 Pages: 5 - 5
